DE69005679T2 - Zusammensetzung mit einer Verbindung der Vitamin B-Gruppe und ihre Herstellung. - Google Patents

Zusammensetzung mit einer Verbindung der Vitamin B-Gruppe und ihre Herstellung.

Info

Publication number
DE69005679T2
DE69005679T2 DE69005679T DE69005679T DE69005679T2 DE 69005679 T2 DE69005679 T2 DE 69005679T2 DE 69005679 T DE69005679 T DE 69005679T DE 69005679 T DE69005679 T DE 69005679T DE 69005679 T2 DE69005679 T2 DE 69005679T2
Authority
DE
Germany
Prior art keywords
vitamin
composition
group
compound
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69005679T
Other languages
English (en)
Other versions
DE69005679D1 (de
Inventor
Seiji Izuhara
Yoshitomi Kakiguchi
Kunihiko Yokota
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of DE69005679D1 publication Critical patent/DE69005679D1/de
Publication of DE69005679T2 publication Critical patent/DE69005679T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
DE69005679T 1989-03-29 1990-03-23 Zusammensetzung mit einer Verbindung der Vitamin B-Gruppe und ihre Herstellung. Expired - Fee Related DE69005679T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7907689 1989-03-29

Publications (2)

Publication Number Publication Date
DE69005679D1 DE69005679D1 (de) 1994-02-17
DE69005679T2 true DE69005679T2 (de) 1994-06-23

Family

ID=13679802

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69005679T Expired - Fee Related DE69005679T2 (de) 1989-03-29 1990-03-23 Zusammensetzung mit einer Verbindung der Vitamin B-Gruppe und ihre Herstellung.

Country Status (7)

Country Link
US (1) US5064829A (de)
EP (1) EP0390435B1 (de)
JP (1) JP2922967B2 (de)
AT (1) ATE99545T1 (de)
DE (1) DE69005679T2 (de)
DK (1) DK0390435T3 (de)
ES (1) ES2062341T3 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0497177T3 (da) * 1991-01-28 1995-04-10 Hoffmann La Roche Vitaminholdige formuleringer og fremstilling deraf
US6265391B1 (en) 1995-10-17 2001-07-24 Upsher-Smith Laboratories, Inc. Method for preventing peripheral nerve damage
US6235947B1 (en) * 1997-04-14 2001-05-22 Takeda Chemical Industries, Ltd. D-mannitol and its preparation
ATE202768T1 (de) 1996-04-16 2001-07-15 Takeda Chemical Industries Ltd D-mannit und seine herstellung
CN1285753A (zh) * 1997-12-02 2001-02-28 鲍德杰克特疫苗公司 透皮给药微粒疫苗组合物
US6881723B1 (en) 1998-11-05 2005-04-19 Powderject Vaccines, Inc. Nucleic acid constructs
US7022320B1 (en) 1999-02-09 2006-04-04 Powderject Vaccines, Inc. Mycobacterium tuberculosis immunization
US7196066B1 (en) 1999-11-03 2007-03-27 Powderject Vaccines, Inc. DNA-vaccines based on constructs derived from the genomes of human and animal pathogens
MY148466A (en) * 2001-10-26 2013-04-30 Merck Frosst Canada Ltd Granule formulation
CN1926213B (zh) 2004-03-03 2011-01-26 日本化药株式会社 偏光元件用水基粘合剂和用其得到的偏振器
WO2005097085A1 (en) * 2004-04-08 2005-10-20 Micro Nutrient, Llc Nutrient system for individualized responsive dosing regimens
US7850987B2 (en) 2004-04-08 2010-12-14 Micronutrient, Llc Nutrient composition(s) and system(s) for individualized, responsive dosing regimens
US7785619B2 (en) 2004-04-08 2010-08-31 Micro Nutrient, Llc Pharmanutrient composition(s) and system(s) for individualized, responsive dosing regimens
JP2011103818A (ja) * 2009-11-18 2011-06-02 Pokka Corp 液状食品の噴霧乾燥方法及び乾燥された液状食品

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3145146A (en) * 1961-10-31 1964-08-18 Warner Lambert Pharmaceutical Modified mannitol for pharmaceutical tablets
US3384546A (en) * 1965-05-28 1968-05-21 Miles Lab Directly compressed low-density crystalline sorbitol pharmaceutical tablets
US3446899A (en) * 1968-01-25 1969-05-27 Hoffmann La Roche Vitamin compositions produced by direct compression
US3721725A (en) * 1970-08-14 1973-03-20 Du Pont Process for preparing powder blends
AU561367B2 (en) * 1983-05-02 1987-05-07 Scherer, R.P. Pty. Ltd. Vitamin composition with enhanced bioavailability
US4533542A (en) * 1983-08-22 1985-08-06 Eli Lilly And Company Pharmaceutical compositions for storage in plastic containers and process therefor
US4684643A (en) * 1983-08-22 1987-08-04 Eli Lilly And Company Pharmaceutical compositions for storage in plastic containers and process therefor
WO1985001877A1 (en) * 1983-10-24 1985-05-09 Basf Wyandotte Corporation A process for preparation spray-dried powders containing a water-soluble vitamin and powders prepared thereby
US4605666A (en) * 1983-10-24 1986-08-12 Basf Corporation Process for preparing spray-dried powders containing a water-soluble vitamin and powders prepared thereby
CA1279574C (en) * 1985-04-17 1991-01-29 Jeffrey L. Finnan Process for lubricating water-soluble vitamin powders
AU587863B2 (en) * 1985-10-07 1989-08-31 Basf Aktiengesellschaft Vitamin-containing granules and production thereof

Also Published As

Publication number Publication date
JPH037230A (ja) 1991-01-14
US5064829A (en) 1991-11-12
ATE99545T1 (de) 1994-01-15
EP0390435B1 (de) 1994-01-05
EP0390435A1 (de) 1990-10-03
ES2062341T3 (es) 1994-12-16
DE69005679D1 (de) 1994-02-17
JP2922967B2 (ja) 1999-07-26
DK0390435T3 (da) 1994-03-21

Similar Documents

Publication Publication Date Title
DE69005679T2 (de) Zusammensetzung mit einer Verbindung der Vitamin B-Gruppe und ihre Herstellung.
IT8024820A0 (it) Composizioni germicide a base di iodio dotate di maggiore stabilita'.
DE3763011D1 (de) Systeme zur verbesserung der durchdringungsfaehigkeit und deren zubereitung.
ES2152259T3 (es) Productos de cereales listos para comer enriquecidos con beta-caroteno.
SE7703206L (sv) Stabiliserad ureas
FR2601855B1 (fr) Composition destinee a la conservation du fourrage.
NO902488L (no) Karboplatinapreparat.
ES2077749T3 (es) Preparacion de alfa-olefina por etenolisis.
ATE52691T1 (de) Pharmazeutische zubereitung.
PH27567A (en) Topical compositions
TR20925A (tr) Herbisit antidotlar olarak ikame edilmis 2-imino-1.3-ditio ve 1.3-oksatio heterosiklik terkipler
JPS52152445A (en) Stabilized halogen-containing resin compositions
NO943373D0 (no) Psyliumholdig sammensatt blandingsdrikk
DE3788953T2 (de) Polyamid-Zusammensetzung.
DE3781017D1 (de) Cytotoxische zusammensetzung aus "killer"-zellen.
JPS5550072A (en) Aqueous ink composition
USD221110S (en) Duck bo at or the like
USD257545S (en) Ball paddle for table game
IT7967250A0 (it) Derivati della i.4 benzazina parti colarmente utili come microbicidi per uso agricolo ed orticolo
JPS5581803A (en) Repellent with durability
JPS57141449A (en) Antproofing resin composition
JPS537697A (en) 3-phenylhydantoic acid derivatives, their preparation and nonmedical fungicides containing the same as active constituents
JPS559027A (en) Stable germicide composition
FR2575070B3 (fr) Composition a effet assainissant, en particulier pour le parfumage d'air ambiant
JPS57177667A (en) Spice composition

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: BASF AG, 67063 LUDWIGSHAFEN, DE

8327 Change in the person/name/address of the patent owner

Owner name: BASF SE, 67063 LUDWIGSHAFEN, DE

8339 Ceased/non-payment of the annual fee